| Literature DB >> 33046461 |
Heba AlSawahli1, Ian McCormick2, Caleb D Mpyet3, Gamal Ezzelarab4, Mohammad Shalaby4.
Abstract
OBJECTIVES: To determine the prevalence and causes of blindness and vision impairment, and the coverage and quality of cataract surgical services, among population aged 50 years and older in Sohag governorate in Egypt.Entities:
Keywords: cataract and refractive surgery; epidemiology; health policy; ophthalmology; public health
Mesh:
Year: 2020 PMID: 33046461 PMCID: PMC7552864 DOI: 10.1136/bmjopen-2019-036337
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Age and sex distribution of survey participants compared with the 2016 census data for Sohag governorate
| Men | Women | Total | ||||||||||
| Sample | Governorate | Sample | Governorate | Sample | Governorate | |||||||
| n | % | n | % | n | % | n | % | n | % | n | % | |
| 50–59 | 995 | 41.6 | 168 208 | 51.4 | 731 | 44.5 | 157 701 | 52.5 | 1726 | 42.8 | 325 909 | 51.9 |
| 60–69 | 846 | 35.4 | 103 632 | 31.7 | 568 | 34.5 | 90 387 | 30.1 | 1414 | 35.1 | 194 019 | 30.9 |
| 70–79 | 411 | 17.2 | 39 858 | 12.2 | 261 | 15.9 | 37 423 | 12.5 | 672 | 16.7 | 77 281 | 12.3 |
| 80+ | 137 | 5.7 | 15 268 | 4.7 | 84 | 5.1 | 15 033 | 5.0 | 221 | 5.5 | 30 301 | 4.8 |
| Total | 2389 | 100.0 | 326 966 | 100.0 | 1644 | 100.0 | 300 544 | 100.0 | 4033 | 100.0 | 627 510 | 100.0 |
Age-adjusted and sex-adjusted prevalence of bilateral blindness, SVI, MVI and EVI, and the projected number of people aged 50 years and older affected in Sohag governorate
| Men | Women | P value* | Total | ||||
| Projected number of people aged 50 years and older | % (95% CI) | Projected number of people aged 50 years and older | % (95% CI) | Projected number of people aged 50 years and older | % (95% CI) | ||
| Blindness | 16 115 | 4.9 (3.9 to 6.0) | 20 598 | 6.9 (5.1 to 8.6) | 0.046 | 36 715 | 5.9 (4.8 to 6.9) |
| SVI | 10 459 | 3.2 (2.4 to 4.0) | 19 173 | 6.4 (4.7 to 8.0) | <0.001 | 29 639 | 4.7 (3.8 to 5.7) |
| MVI | 52 089 | 15.9 (13.5 to 18.3) | 66 348 | 22.1 (19.7 to 24.5) | <0.001 | 118 446 | 18.9 (16.8 to 21.0) |
| EVI | 54 664 | 16.7 (14.6 to 18.8) | 56 792 | 18.9 (16.8 to 21.0) | 0.151 | 111 452 | 17.8 (16.0 to 19.5) |
*Two-sample test of proportions using the adjusted prevalence estimates for male and female subgroups.
EVI, early vision impairment; MVI, moderate vision impairment; SVI, severe vision impairment.
Causes of blindness, SVI, MVI and EVI based on participants’ presenting VA
| Blindness | Severe VI | Moderate VI | Early VI | |||||
| n | % | n | % | n | % | n | % | |
| Refractive error | 1 | 0.4 | 3 | 1.5 | 109 | 13.6 | 394 | 53.6 |
| Aphakia, uncorrected | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cataract, untreated | 105 | 41.2 | 121 | 60.5 | 366 | 45.8 | 151 | 20.5 |
| Cataract surgical complications | 20 | 7.8 | 20 | 10 | 53 | 6.6 | 23 | 3.1 |
| Trachomatous corneal opacity | 2 | 0.8 | 3 | 1.5 | 11 | 1.4 | 6 | 0.8 |
| Non-trachomatous corneal opacity | 40 | 15.7 | 14 | 7 | 34 | 4.3 | 11 | 1.5 |
| Phthisis | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Onchocerciasis | 1 | 0.4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Glaucoma | 21 | 8.2 | 4 | 2 | 12 | 1.5 | 7 | 1 |
| Diabetic retinopathy | 1 | 0.4 | 4 | 2 | 14 | 1.8 | 5 | 0.7 |
| Age Related Macular Degeneration | 5 | 2 | 3 | 1.5 | 9 | 1.1 | 4 | 0.5 |
| Other posterior segment disease | 37 | 14.5 | 25 | 12.5 | 183 | 22.9 | 121 | 16.5 |
| All other globe/Central Nervous System | 22 | 8.6 | 3 | 1.5 | 9 | 1.1 | 13 | 1.8 |
| Total | 255 | 100 | 200 | 100 | 800 | 100 | 735 | 100 |
EVI, early vision impairment; MVI, moderate vision impairment; SVI, severe vision impairment; VA, visual acuity.
Age-adjusted and sex-adjusted prevalence of bilateral cataract blindness, SVI, MVI and EVI (with best corrected VA) and the projected number of people aged 50 years and older affected in Sohag governorate
| Men | Women | Total | ||||
| Projected number of people aged 50 years and older | % (95% CI) | Projected number of people aged 50 years and older | % (95% CI) | Projected number of people aged 50 years and older | % (95% CI) | |
| Blindness | 4808 | 1.5 (0.9 to 2.0) | 4750 | 1.6 (0.8 to 2.4) | 9558 | 1.5 (1.0 to 2.0) |
| SVI | 3043 | 0.9 (0.5 to 1.4) | 5332 | 1.8 (1.0 to 2.5) | 8375 | 1.3 (0.9 to 1.8) |
| MVI | 15 636 | 4.8 (3.6 to 5.9) | 17 761 | 5.9 (4.6 to 7.2) | 33 397 | 5.3 (4.3 to 6.3) |
| EVI | 11 745 | 1.8 (0.7 to 2.9) | 10 992 | 1.8 (0.7 to 2.9) | 22 737 | 1.8 (1.0 to 2.7) |
EVI, early vision impairment; MVI, moderate vision impairment; SVI, severe vision impairment; VA, visual acuity.
CSC and effective CSC (in persons) by level of vision impairment due to operable cataract
| Men (%) | Women (%) | Total (%) | |
| CSC | |||
| VA <3/60 | 83.4 | 89.2 | 86.6 |
| VA <6/60 | 77.9 | 80.6 | 79.3 |
| VA <6/18 | 59.5 | 63 | 61.2 |
| Effective CSC | |||
| VA <3/60 | 51 | 39 | 44.9 |
| VA <6/60 | 45.9 | 34.9 | 40.4 |
| VA <6/18 | 33.9 | 26.1 | 30.2 |
CSC, cataract surgical coverage; VA, visual acuity.